Langerhans cell histiocytosis and dermatophytosis.

[1]  S. Leikin.  Immunobiology of histiocytosis-X. , 1987, Hematology/oncology clinics of North America.

[2]  C. Pochedly,et al.  Histiocytosis-X: an overview. , 1987, Hematology/oncology clinics of North America.

[3]  F. Gonzalez-crussi,et al.  Histiocytosis X: A seven-year experience at a children's hospital. , 1985, Journal of the American Academy of Dermatology.

[4]  K. Kragballe,et al.  Histiocytosis X–an immune deficiency disease? Studies on antibody‐dependent monocyte‐mediated cytotoxicity , 1981, The British journal of dermatology.

[5]  M. O'Leary,et al.  The immune system and the histiocytosis syndromes. , 1981, The American journal of pediatric hematology/oncology.

[6]  P. Lavin,et al.  Histiocytosis-X: Demonstration of Abnormal Immunity, T-Cell Histamine H2-Receptor Deficiency, and Successful Treatment with Thymic Extract , 1981 .

[7]  A. Ahmed,et al.  Trichophytin reactions in children with tinea capitis. , 1978, Archives of dermatology.

[8]  E. Stiehm,et al.  Combined immunodeficiency presenting as the Letterer-Siwe syndrome. , 1974, The Journal of pediatrics.

[9]  M. Rinaldi,et al.  Immunologic susceptibility to chronic dermatophytosis. , 1974, Archives of dermatology.

[10]  S. Leikin,et al.  Immunologic parameters in histiocytosis‐X , 1973 .